Fermion and Pharmatory have recently signed formal collaboration agreement to provide CDMO services for customers’ API development projects from preclinical to commercial stages. Our complementary service packages enable a seamless project transfer from early development and small scale manufacturing to further optimization and scale-up together with commercial production. Fermion is a fully owned subsidiary of Orion Corporation located in Finland, Europe.
Pharmatory and Orion Corporation have worked together for over 10 years in various API development projects. This proven collaboration, supported by our shared work ethics, standard practices and cultural coherence, ensures a safe and smooth transfer of all project-related information between the companies. The customer benefits from this collaboration as an unbroken path for API development and manufacturing for full product lifecycle and smaller investments in project outsourcing.
Please contact us for further details about our collaboration.
Mr. Niko Saari joined the Pharmatory team of chemistry experts in October 2017. Niko graduated from the University of Oulu in 2016 and his M.Sc. thesis in synthetic organic chemistry was titled ‘Mono- and regioselectivity in Suzuki-Miyaura cross-coupling reactions.’ He is eager to put his skills and enthusiasm into practise to help our customers achieve their goals.
Pharmatory participated BioPharm America in Boston 26.-27.9.2017. We thorougly enjoyed both the partnering meetings and the many informal discussions during the breaks and socializing time. Many thanks again to everyone involved and let’s keep on building further on the foundation laid in Boston!